TrialEuropean journal of clinical pharmacology2012

CYP2C9 3 and 13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects.

Chang-Ik Choi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.